Athersys Inc. is a biopharmaceutical company that is focused in the field of regenerative medicine. It is engaged in the discovery and development of best-in-class therapies designed to extend and enhance the quality of human life.


Updates from The Motley Fool

Latest updates on Athersys from Fool.com.


Stock Performance

ATHX vs. S&P 500 | 2 Year Performance
View Interactive ATHX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Athersys.
Current Price: $2.22
Prev Close: $2.20
Open: $2.19
Bid: $2.15
Ask: $2.35
Day's Range: $2.12 - $2.22
52wk Range: $0.94 - $2.90
Volume: 303,569
Avg Vol 677,155
Market Cap: $184.89M
P/E (ttm): 110.00
EPS (ttm): $0.02
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Athersys.
CAPS Rating 1 out of 5
 
78 Outperform
21 Underperform
CAPS All Stars
 
5 Outperform
14 Underperform

How do you think Athersys will perform against the market?



You pick for Athersys is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Gil Van Bokkelen, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Athersys.

Athersys Inc. is a biopharmaceutical company that is focused in the field of regenerative medicine. It is engaged in the discovery and development of best-in-class therapies designed to extend and enhance the quality of human life.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers